Omentin-1 exerts bone-sparing effect in ovariectomized mice

Action of RANKL and OPG for Osteoclastogenesis

(2012) Yasuhiro Kobayashi et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells

(2011) Hideyuki Yamawaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Metabolic syndrome: definitions and controversies

(2011) Eva Kassi et al.   BMC Medicine

Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women

(2011) Yun Kyung Jeon et al.   ENDOCRINE JOURNAL

Diet-induced obesity alters bone remodeling leading to decreased femoral trabecular bone mass in mice

(2010) Jay J. Cao et al.   Annals of the New York Academy of Sciences

Fat and bone

(2010) Ian R. Reid   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels

(2010) Hideyuki Yamawaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats

(2010) Yun Jung Bae et al.   CALCIFIED TISSUE INTERNATIONAL

Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes

(2010) Hong-Yan Pan et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index

(2010) E. A. Greco et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women

(2010) Hui Xie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Visceral Fat Is a Negative Predictor of Bone Density Measures in Obese Adolescent Girls

(2010) Melissa Russell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The metabolic syndrome: time to get off the merry-go-round?

(2010) G. M. Reaven   JOURNAL OF INTERNAL MEDICINE

Metabolic syndrome and bone metabolism

(2010) José L. Hernández et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Circulating omentin concentration increases after weight loss

(2010) José Moreno-Navarrete et al.   Nutrition & Metabolism

Association between metabolic syndrome (MS) and bone mineral loss: a cross-sectional study in Puli Township in Taiwan

(2009) Yao-Hsien Tseng et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

The Role of Body Mass Index, Insulin, and Adiponectin in the Relation Between Fat Distribution and Bone Mineral Density

(2009) M. Carola Zillikens et al.   CALCIFIED TISSUE INTERNATIONAL

In Vitroandin VivoEffects of Adiponectin on Bone

(2009) Garry A. Williams et al.   ENDOCRINOLOGY

A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans

(2009) Hui Li et al.   JOURNAL OF CLINICAL INVESTIGATION

The development and endocrine functions of adipose tissue

(2009) Sylvia P. Poulos et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The relationship between low bone mass and metabolic syndrome in Korean women

(2009) D.-K. Hwang et al.   OSTEOPOROSIS INTERNATIONAL

Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice

(2008) Jianghua Liu et al.   BONE

Decreased plasma omentin-1 levels in Type 1 diabetes mellitus

(2008) B. K. Tan et al.   DIABETIC MEDICINE

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

(2008) Ann E. Kearns et al.   ENDOCRINE REVIEWS

Adiponectin Is a Negative Regulator of Bone Mineral and Bone Strength in Growing Mice

(2008) Kafi N. Ealey et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

High bone mineral density is associated with high body mass index

(2008) S. Morin et al.   OSTEOPOROSIS INTERNATIONAL

Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years

(2008) S. Morin et al.   OSTEOPOROSIS INTERNATIONAL